Publications

Articles scientifiques

Efficacy and safety of ervogastat alone and in combination with clesacostat in patients with biopsy-confirmed metabolic dysfunction-associated steatohepatitis and F2–F3 fibrosis (MIRNA): results from a phase 2, randomised, double-blind, double-dummy study

Octobre 2025

Abstract Ervogastat, a diacylglycerol acyltransferase 2 (DGAT2) inhibitor, and clesacostat, an acetyl-coenzyme ...

Types

Sujets

Formations à venir

Webinaire – Surveillance du VIH au Québec : portrait épidémiologique 2023-2024 et tendances récentes

Webinaire – VHB et VHD : il est temps de trouver et traiter davantage de patients

Webinaire – Engager, traiter et retenir : Le rôle des pair·es dans les soins de l’hépatite C

Actualités

Infolettres

Congrès externes à venir

Publications

À la une

Guérison du VHC par AAD : taux d’ALAT et devenir hépatique chez des PVVIH présentant une co-infection par VHB et VHD

INSPQ (rapport) – Consommation de drogues, expérience de surdose et utilisation des services en réduction des méfaits

Lignes directrices

Outils cliniques

À la une

OMS – Premières lignes directrices sur la doxy-PEP

Substances psychoactives, tabac et jeux d’argent | INSPQ

Résultat(s)

Publications

Types

Sujets

Spécialités

Dernières publications

Étude épidémiologique (ASPC) – Estimations nationales de l’hépatite B et de l’hépatite C pour 2021

ESCODI – Optimisation du rôle du pharmacien communautaire auprès des personnes en situation de précarité

ESCODI – Deux nouveaux outils pour l’offre de services en dépendance et itinérance

Un guide de santé sexuelle pour hommes trans et personnes transmasculines, queers et non binaires

Prophylaxie postexposition par la doxycycline pour prévenir les infections bactériennes transmissibles sexuellement

Distinct Gut Microbiota Signatures Are Associated with Severity of Metabolic Dysfunction-Associated Steatotic Liver Disease in People with HIV

Prevalence, treatment and follow up for lymphogranuloma venereum serovars of Chlamydia trachomatis among Gay, Bisexual and Other Men who have Sex with Men Attending STI Clinics in Alberta, Canada, 2018-2022

Hepatitis C virus reinfection among people who inject drugs in the country of Georgia and injection-related risk factors: Implications for HCV elimination in the EECA region

Efficacy and safety of ervogastat alone and in combination with clesacostat in patients with biopsy-confirmed metabolic dysfunction-associated steatohepatitis and F2–F3 fibrosis (MIRNA): results from a phase 2, randomised, double-blind, double-dummy study

Association between HIV and cancer risk

CHANGE-Rx: frailty, falls, polypharmacy, and inappropriate medication use in a Canadian cohort of people aged 65 years and older with HIV

Socio-structural barriers to mental health services among women living with HIV in Metro Vancouver, Canada

Clinical Predictors and Incidence of Kaposi Sarcoma Among Males With HIV in the Treat-All Era in the United States and Canada

Risk of hepatitis C virus reinfection after direct-acting antiviral treatment among HIV-positive men who have sex with men and people who inject drugs: a systematic review and meta-analysis

Perceptions about hepatitis C and barriers and enablers to screening and treatment among Egyptian immigrants to Canada: a theory-informed qualitative study

CHIME: Sofosbuvir/Velpatasvir (S/V) for the Treatment of HCV Infection Among Vulnerable Inner-City Residents

ASPC – VIH au Canada, Rapport de Surveillance en date du 31 décembre 2023 : Sommaire

Associations between HIV serostatus and coronary artery plaque volume progression

The evolving HIV epidemic in Ontario, Canada: A retrospective analysis of new HIV diagnoses to identify subpopulations with persistent risk of HIV transmission

Are You Serious? The Absurdity of Policies Defining Two Sexes … Banning One and Erasing Others!

Switching to bictegravir/emtricitabine/tenofovir alafenamide from efavirenz/emtricitabine/tenofovir disoproxil in virologically suppressed people with HIV: findings from a non-randomized clinical trial (EBONY study)

Unhealthy Behaviours and All-Cause Mortality Among People With Chronic Hepatitis B, With and Without Hepatitis Delta (ANRS CO22 HEPATHER)

Risk of HBV reactivation in HBV/HCV-co-infected HCV-treated patients: A single-center study

Treatment options to support the elimination of hepatitis C: an open-label, factorial, randomised controlled non-inferiority trial

Boîte à outils (IUD) – Savoir reconnaître et agir lors d’une intoxication sévère ou d’une surdose liée à la consommation de substances psychoactives ou d’un sevrage d’alcool

Canada – Rapport d’étape 2023-2024 sur les infections transmissibles sexuellement et par le sang

Interrelationship between chemsex engagement and PrEP (pre-exposure prophylaxis) experience in men who have sex with men: a community-based cross-sectional study

Prevalence of Sexually Transmitted Infections Among Cisgender Women Coming to a Walk-In Center

Impact of Depression at HIV PrEP Initiation on Sustained PrEP Care Engagement Among US Gay and Bisexual Men

Potential Impact of Doxycycline Post-Exposure Prophylaxis on Tetracycline Resistance in Neisseria gonorrhoeae and Colonization With Tetracycline-Resistant Staphylococcus aureus and Group A Streptococcus